|
|
|
|
About ACGT
|
Scientific Advisory Council
![]() Robert L. Martuza, M.D., F.A.C.S.
Vice Chair for Research and Chief, Chief of Neurological Services Massachusetts General Hospital Professor of Neurosurgery Harvard Medical School Boston, Massachusetts The first publication of this concept was in Science in 1991, and Dr. Martuza has since been recognized as the intellectual authority on this topic. This has since led to a large and developing field with multiple laboratories worldwide studying oncolytic viruses of various types for cancer therapy. Dr. Martuza and his colleagues have focused on genetically engineered vectors derived from the common cold sore virus, Herpes Simplex Virus-1. They have taken these studies from the bench to the bedside and have completed the first Phase 1 clinical study in patients with recurrent glioblastoma, a fatal cancer of the brain. < Return to Scientific Advisory Council |
|
©2007 Alliance for Cancer Gene Therapy 96 Cummings Point Road, Stamford, CT, 06902 |
|